BiologicsMD is the UA startup and business-plan competition team that has been taking the state (the nation, the world?) by storm in 2010.

BiologicsMD, which is developing a new treatment for osteoporosis, is smack dab in the middle of a whirlwind adventure. Their latest excursion will take them to Times Square in New York for the second time this month, where team members will ring Nasdaq’s closing bell.

The Biologics team, which has developed a treatment for osteoporosis that sticks to the bone and spurs new bone growth, will ring the bell at the Nasdaq on Friday in New York.